<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB00639</drugbank-id>
  <drugbank-id>APRD00834</drugbank-id>
  <name>Butoconazole</name>
  <description>Butoconazole is an imidazole antifungal used in gynecology.</description>
  <cas-number>64872-76-0</cas-number>
  <unii>0Q771797PH</unii>
  <average-mass>411.776</average-mass>
  <monoisotopic-mass>410.017802365</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference>Laszlo Czibula, Laszlo Dobay, Eva Werkne Papp, Judit Nagyne Bagdy, Ferenc Sebok, "High Purity Butoconazole Nitrate with Specified Particle Size and a Process for the Preparation Thereof." U.S. Patent US20080221190, issued September 11, 2008.</synthesis-reference>
  <indication>For the local treatment of vulvovaginal candidiasis (infections caused by Candida)</indication>
  <pharmacodynamics>Butoconazole is an imidazole derivative that has fungicidal activity &lt;i&gt;in vitro&lt;/i&gt; against &lt;i&gt;Candida&lt;/i&gt; spp. and has been demonstrated to be clinically effective against vaginal infections due to &lt;i&gt;Candida albicans&lt;/i&gt;. &lt;i&gt;Candida albicans&lt;/i&gt; has been identified as the predominant species responsible for vulvovaginal candidasis.</pharmacodynamics>
  <mechanism-of-action>The exact mechanism of the antifungal action of butoconazole is unknown, however, it is presumed to function as other imidazole derivatives via inhibition of steroid synthesis. Imidazoles generally inhibit the conversion of lanosterol to ergosterol via the inhibition of the enzyme cytochrome P450 14&amp;alpha;-demethylase, resulting in a change in fungal cell membrane lipid composition. This structural change alters cell permeability and, ultimately, results in the osmotic disruption or growth inhibition of the fungal cell.</mechanism-of-action>
  <toxicity>Oral, rat: LD&lt;sub&gt;50&lt;/sub&gt; = &gt;1720 mg/kg.</toxicity>
  <metabolism/>
  <absorption>Following vaginal administration of butoconazole nitrate vaginal cream, 2% to 3 women, 1.7% (range 1.3-2.2%) of the dose was absorbed on average.</absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as phenylbutylamines. These are compounds containing a phenylbutylamine moiety, which consists of a phenyl group substituted at the fourth carbon by an butan-1-amine.</description>
    <direct-parent>Phenylbutylamines</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Benzenoids</superclass>
    <class>Benzene and substituted derivatives</class>
    <subclass>Phenylbutylamines</subclass>
    <alternative-parent>Alkylarylthioethers</alternative-parent>
    <alternative-parent>Aryl chlorides</alternative-parent>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Dichlorobenzenes</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>N-substituted imidazoles</alternative-parent>
    <alternative-parent>Organochlorides</alternative-parent>
    <alternative-parent>Organonitrogen compounds</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Sulfenyl compounds</alternative-parent>
    <alternative-parent>Thiophenol ethers</alternative-parent>
    <substituent>1,3-dichlorobenzene</substituent>
    <substituent>Alkylarylthioether</substituent>
    <substituent>Aromatic heteromonocyclic compound</substituent>
    <substituent>Aryl chloride</substituent>
    <substituent>Aryl halide</substituent>
    <substituent>Aryl thioether</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Azole</substituent>
    <substituent>Chlorobenzene</substituent>
    <substituent>Halobenzene</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Imidazole</substituent>
    <substituent>N-substituted imidazole</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organochloride</substituent>
    <substituent>Organohalogen compound</substituent>
    <substituent>Organoheterocyclic compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Organosulfur compound</substituent>
    <substituent>Phenylbutylamine</substituent>
    <substituent>Sulfenyl compound</substituent>
    <substituent>Thioether</substituent>
    <substituent>Thiophenol ether</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT001012</drugbank-id>
      <name>Butoconazole nitrate</name>
      <unii>4805237NP5</unii>
      <cas-number>64872-77-1</cas-number>
      <inchikey>ZHPWRQIPPNZNML-UHFFFAOYSA-N</inchikey>
      <average-mass>474.78</average-mass>
      <monoisotopic-mass>473.0134457</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="english" coder="">1-[4-(4-Chloro-phenyl)-2-(2,6-dichloro-phenylsulfanyl)-butyl]-1H-imidazole</synonym>
    <synonym language="spanish/german" coder="inn">Butoconazol</synonym>
    <synonym language="english/french" coder="inn">Butoconazole</synonym>
    <synonym language="latin" coder="inn">Butoconazolum</synonym>
  </synonyms>
  <products>
    <product>
      <name>Gynazole 1</name>
      <labeller>Amag Pharmaceuticals Inc</labeller>
      <ndc-id/>
      <ndc-product-code>64011-246</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-12-27</started-marketing-on>
      <ended-marketing-on>2016-10-01</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength>100 mg/5g</strength>
      <route>Vaginal</route>
      <fda-application-number>ANDA200923</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gynazole 1</name>
      <labeller>Perrigo New York Inc</labeller>
      <ndc-id/>
      <ndc-product-code>45802-396</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-04-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength>100 mg/5g</strength>
      <route>Vaginal</route>
      <fda-application-number>ANDA200923</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gynazole-1</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-4838</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-06-30</started-marketing-on>
      <ended-marketing-on>2008-06-30</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength>20 mg/1g</strength>
      <route>Vaginal</route>
      <fda-application-number>NDA019881</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gynazole-1</name>
      <labeller>Ther Rx Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>64011-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-11-23</started-marketing-on>
      <ended-marketing-on>2011-06-30</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength>20 mg/1g</strength>
      <route>Vaginal</route>
      <fda-application-number>NDA072838</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Gynazole.1</name>
      <labeller>Ferring Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02248417</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-04-20</started-marketing-on>
      <ended-marketing-on>2014-01-15</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Vaginal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Femstat</name>
      <company>Bayer</company>
    </international-brand>
    <international-brand>
      <name>Femstat 3</name>
      <company>Bayer</company>
    </international-brand>
    <international-brand>
      <name>Gynazol</name>
      <company>Gedeon Richter</company>
    </international-brand>
    <international-brand>
      <name>Gynazole</name>
      <company>OM</company>
    </international-brand>
    <international-brand>
      <name>Gynofort</name>
      <company>Gedeon Richter</company>
    </international-brand>
    <international-brand>
      <name>Gynomyk</name>
      <company>Will</company>
    </international-brand>
    <international-brand>
      <name>Inulead</name>
      <company>Fuji Yakuhin</company>
    </international-brand>
    <international-brand>
      <name>Mycelex-3</name>
      <company>Bayer</company>
    </international-brand>
    <international-brand>
      <name>Volusol</name>
      <company>Farmindustria</company>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Gynazole-1</name>
      <ingredients>Butoconazole</ingredients>
    </mixture>
    <mixture>
      <name>Gynazole-1</name>
      <ingredients>Butoconazole</ingredients>
    </mixture>
    <mixture>
      <name>Gynazole 1</name>
      <ingredients>Butoconazole</ingredients>
    </mixture>
    <mixture>
      <name>Gynazole 1</name>
      <ingredients>Butoconazole</ingredients>
    </mixture>
    <mixture>
      <name>Gynazole.1</name>
      <ingredients>Butoconazole</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>A-S Medication Solutions LLC</name>
      <url>http://orders.a-smeds.com</url>
    </packager>
    <packager>
      <name>Bayer Healthcare</name>
      <url>http://www.bayerhealthcare.com</url>
    </packager>
    <packager>
      <name>KV Pharmaceutical Co.</name>
      <url>http://www.kvpharmaceutical.com</url>
    </packager>
    <packager>
      <name>Pharmedix</name>
      <url>http://www.pharmedixrx.com</url>
    </packager>
    <packager>
      <name>Physicians Total Care Inc.</name>
      <url>http://www.physicianstotalcare.com</url>
    </packager>
    <packager>
      <name>Ther-Rx Corp.</name>
      <url>http://www.ther-rx.com</url>
    </packager>
  </packagers>
  <manufacturers>
    <manufacturer generic="false" url="">Roche palo alto llc</manufacturer>
    <manufacturer generic="false" url="">Bayer healthcare llc</manufacturer>
    <manufacturer generic="false" url="">Kv pharmaceutical co</manufacturer>
  </manufacturers>
  <prices>
    <price>
      <description>Gynazole-1 cream</description>
      <cost currency="USD">10.89</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>Femstat 3 cream</description>
      <cost currency="USD">0.96</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Antifungal Agents</category>
      <mesh-id>D000935</mesh-id>
    </category>
    <category>
      <category>Antifungal Agents (Vaginal)</category>
      <mesh-id/>
    </category>
    <category>
      <category>Azole Antifungals</category>
      <mesh-id/>
    </category>
    <category>
      <category>Genito Urinary System and Sex Hormones</category>
      <mesh-id/>
    </category>
    <category>
      <category>Gynecological Antiinfectives and Antiseptics</category>
      <mesh-id/>
    </category>
    <category>
      <category>Imidazole Derivatives</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Fungi, yeast and protozoans</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Cream</form>
      <route>Vaginal</route>
      <strength>100 mg/5g</strength>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Vaginal</route>
      <strength>20 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Vaginal</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="G01AF20">
      <level code="G01AF">Imidazole derivatives</level>
      <level code="G01A">ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS</level>
      <level code="G01">GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS</level>
      <level code="G">GENITO URINARY SYSTEM AND SEX HORMONES</level>
    </atc-code>
    <atc-code code="G01AF15">
      <level code="G01AF">Imidazole derivatives</level>
      <level code="G01A">ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS</level>
      <level code="G01">GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS</level>
      <level code="G">GENITO URINARY SYSTEM AND SEX HORMONES</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries/>
  <fda-label>//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00639.pdf?1265922803</fda-label>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00639.pdf?1265922742</msds>
  <patents>
    <patent>
      <number>5266329</number>
      <country>United States</country>
      <approved>1993-11-30</approved>
      <expires>2010-11-30</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
    <patent>
      <number>5993856</number>
      <country>United States</country>
      <approved>1999-11-30</approved>
      <expires>2017-11-17</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
  </patents>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>6.7</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-5.7</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>8.18e-04 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>6.55</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>1-[4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl]-1H-imidazole</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>butoconazole</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>411.776</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>410.017802365</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>ClC1=CC=C(CCC(CN2C=CN=C2)SC2=C(Cl)C=CC=C2Cl)C=C1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C19H17Cl3N2S</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C19H17Cl3N2S/c20-15-7-4-14(5-8-15)6-9-16(12-24-11-10-23-13-24)25-19-17(21)2-1-3-18(19)22/h1-5,7-8,10-11,13,16H,6,9,12H2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>SWLMUYACZKCSHZ-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>17.82</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>108.99</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>41.01</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>6.78</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>Nitrate salt: 0.26 mg/ml (practically insoluble)</value>
      <source/>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>~159Â°C with decomposition (nitrate salt)</value>
      <source/>
    </property>
    <property>
      <kind>logP</kind>
      <value>6.7</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>1310</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>3240</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>47472</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46508016</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C08065</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D07598</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>43192</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>79206</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA164781353</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP001267</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Butoconazole</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1295</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>RxList</resource>
      <url>http://www.rxlist.com/cgi/generic2/butoconazole.htm</url>
    </external-link>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/myc1567.shtml</url>
    </external-link>
    <external-link>
      <resource>Drugs.com</resource>
      <url>http://www.drugs.com/cdi/butoconazole-cream.html</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0004803</id>
      <name>Ergosterol</name>
      <organism>Candida albicans</organism>
      <actions>
        <action>other</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A16809</ref-id>
            <pubmed-id>2184984</pubmed-id>
            <citation>Pfaller MA, Riley J, Koerner T: Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans. Diagn Microbiol Infect Dis. 1990 Jan-Feb;13(1):31-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>